Trial Profile
A Multi-centers, Randomized, Double-blinded, Parallel Study to Evaluate the Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2019
Price :
$35
*
At a glance
- Drugs DA 9701 (Primary) ; Pantoprazole
- Indications Dyspepsia
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 26 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2013 New trial record